In October 2021 we reported that the United States (US) Preventive Services Task Force was considering making a number of changes to its guidance on taking a daily aspirin to prevent heart disease and ...
Some Other Category
Add categories relevant to your site
Potential Changes to United States (US) guidance on taking daily aspirin to prevent heart disease and stroke
Several news outlets recently reported that the United States (US) Preventive Services Task Force is considering making a number of changes to its guidance on taking a daily aspirin to prevent heart d ...
Guidance on COVID-19 Vaccination
The Add-Aspirin Trial Management Group encourages everyone on the Add-Aspirin trial to have a Covid vaccine if they are advised to do so by their hospital doctor or GP. Add-Aspirin trial participants ...
Re-opening Trial Recruitment in the UK and ROI
We’re pleased to announce that we are now in a position to re-open trial recruitment in the UK and ROI in those centres that have the capacity to begin registering patients again. Please refer to the ...
Updated guidance on use of NSAIDs and COVID-19
There have been a number of reports, particularly on social media, suggesting that non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could worsen symptoms of COVID-19. In response to ...
News and Resources